The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases
- PMID: 2108169
The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases
Abstract
Acetylation of Ser-530 of sheep prostaglandin endoperoxide (PGG/H) synthase by aspirin causes irreversible inactivation of the cyclooxygenase activity of the enzyme. To determine the catalytic function of the hydroxyl group of Ser-530, we used site-directed mutagenesis to replace Ser-530 with an alanine. Cos-1 cells transfected with expression vectors containing the native (Ser-530) or mutant (Ala-530) cDNAs for sheep PGG/H synthase expressed comparable cyclooxygenase and hydroperoxidase activities. Km values for arachidonate (8 microM) and ID50 values for reversible inhibition by the cyclooxygenase inhibitors, flurbiprofen (5 microM), flufenamate (20 microM), and aspirin (20 mM), were also the same for both native and mutant PGG/H synthases; however, only the native enzyme was irreversibly inactivated by aspirin. Thus, the "active site" Ser-530 of PGG/H synthase is not essential for catalysis or substrate binding. Apparently, acetylation of native PGG/H synthase by aspirin introduces a bulky sidechain at position 530 which interferes with arachidonate binding. In related studies, a cDNA for mouse PGG/H synthase was cloned and sequenced. A sequence of 35 residues with Ser-530 at the midpoint was identical in the two proteins. Thus, Ser-530 does lie in a highly conserved region, probably involved in cyclooxygenase catalysis. Sequence comparisons of mouse and sheep PGG/H synthase also provided information about the heme-binding site of the enzyme. The sheep HYPR sequence (residues 274-277), which had been proposed to form a portion of the distal heme-binding site, is not conserved in the mouse PGG/H synthase, suggesting that this region is not the distal heme-binding site. One sequence, TIWLREHNRV (residues 303-312 of the sheep enzyme), is very closely related to the sequence TLW(L)LREHNRL common to thyroid peroxidase and myeloperoxidase. The histidine in this latter sequence is the putative axial heme ligand of these peroxidases. We suggest that the histidine (His-309) of sheep PGG/H synthase sequence is the axial heme ligand of this enzyme.
Similar articles
-
Structure-function relationships in sheep, mouse, and human prostaglandin endoperoxide G/H synthases.Adv Prostaglandin Thromboxane Leukot Res. 1990;20:14-21. Adv Prostaglandin Thromboxane Leukot Res. 1990. PMID: 2144687 Review.
-
Essential histidines of prostaglandin endoperoxide synthase. His-309 is involved in heme binding.J Biol Chem. 1991 Apr 5;266(10):6168-73. J Biol Chem. 1991. PMID: 1901057
-
The aspirin and heme binding sites of PGG/H synthase.Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:77-80. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1825591 No abstract available.
-
Molecular basis for the inhibition of prostanoid biosynthesis by nonsteroidal anti-inflammatory agents.Stroke. 1990 Dec;21(12 Suppl):IV24-8. Stroke. 1990. PMID: 2175460
-
Aspirin--now we can see it.Nat Med. 1995 Sep;1(9):882-3. doi: 10.1038/nm0995-882. Nat Med. 1995. PMID: 7585209 Review. No abstract available.
Cited by
-
Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.J Biol Chem. 2013 Oct 4;288(40):28641-55. doi: 10.1074/jbc.M113.505503. Epub 2013 Aug 16. J Biol Chem. 2013. PMID: 23955344 Free PMC article.
-
Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.Drugs. 1997 Apr;53(4):563-82. doi: 10.2165/00003495-199753040-00003. Drugs. 1997. PMID: 9098660 Review.
-
Mechanistic insights into a classic wonder drug--aspirin.J Am Chem Soc. 2015 Jan 14;137(1):70-3. doi: 10.1021/ja5112964. Epub 2014 Dec 22. J Am Chem Soc. 2015. PMID: 25514511 Free PMC article.
-
Human cyclooxygenase-2 cDNA.Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7384-8. doi: 10.1073/pnas.89.16.7384. Proc Natl Acad Sci U S A. 1992. PMID: 1380156 Free PMC article.
-
Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):925-30. doi: 10.1073/pnas.97.2.925. Proc Natl Acad Sci U S A. 2000. PMID: 10639181 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials